Marshall Wace LLP Lowers Position in Healthpeak Properties, Inc. (NYSE:DOC)

Marshall Wace LLP lessened its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 29.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 402,181 shares of the real estate investment trust's stock after selling 167,491 shares during the period. Marshall Wace LLP owned approximately 0.06% of Healthpeak Properties worth $8,152,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. JPMorgan Chase & Co. raised its stake in Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after acquiring an additional 4,056,931 shares during the last quarter. Geode Capital Management LLC raised its stake in Healthpeak Properties by 3.6% in the 4th quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust's stock worth $371,168,000 after acquiring an additional 638,012 shares during the last quarter. Principal Financial Group Inc. raised its stake in Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after acquiring an additional 17,314,572 shares during the last quarter. Centersquare Investment Management LLC raised its stake in Healthpeak Properties by 3.7% in the 4th quarter. Centersquare Investment Management LLC now owns 11,215,516 shares of the real estate investment trust's stock worth $227,339,000 after acquiring an additional 398,770 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Healthpeak Properties by 0.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust's stock valued at $205,810,000 after buying an additional 53,392 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company's stock.

Analysts Set New Price Targets

A number of research firms have weighed in on DOC. Wedbush reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Monday. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. Evercore ISI reduced their price objective on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday. Robert W. Baird reduced their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Tuesday, February 11th. Finally, Scotiabank reduced their target price on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $23.45.

Healthpeak Properties Price Performance

NYSE DOC traded down $0.06 during mid-day trading on Monday, hitting $17.77. The stock had a trading volume of 6,623,695 shares, compared to its average volume of 4,911,239. The firm's 50 day moving average is $19.53 and its 200 day moving average is $20.53. Healthpeak Properties, Inc. has a twelve month low of $17.33 and a twelve month high of $23.26. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a market capitalization of $12.43 billion, a price-to-earnings ratio of 50.77, a PEG ratio of 2.17 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The firm had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. During the same period in the prior year, the company earned $0.45 EPS. The firm's revenue was up 15.9% compared to the same quarter last year. Equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently announced a dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th will be paid a $0.1017 dividend. This represents a dividend yield of 6.5%. The ex-dividend date of this dividend is Thursday, April 17th. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.

Insiders Place Their Bets

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 11,337 shares of the stock in a transaction dated Monday, April 28th. The stock was acquired at an average cost of $17.68 per share, for a total transaction of $200,438.16. Following the acquisition, the chief executive officer now owns 201,863 shares in the company, valued at $3,568,937.84. This trade represents a 5.95 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John T. Thomas purchased 4,200 shares of the stock in a transaction dated Monday, April 28th. The shares were acquired at an average price of $17.84 per share, with a total value of $74,928.00. Following the completion of the acquisition, the director now owns 813,566 shares in the company, valued at approximately $14,514,017.44. This trade represents a 0.52 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.23% of the company's stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.